Supramolecular host-guest interactions of pseudoginsenoside F11 (cas 19340-14-8) with β- and γ-cyclodextrin: Spectroscopic/spectrometric and computational studies
-
Add time:08/04/2019 Source:sciencedirect.com
Pseudoginsenoside F11 (cas 19340-14-8) (PF11) was described considering its complexation capabilities with β- and γ-cyclodextrin. A merged computational/experimental approach was used, and it was found that the PF11 molecule form a stable inclusion complex with the γ-cyclodextrin, with an association constant of 1.66 × 104 M−1, while it is not able to form an analogously one with the β-cyclodextrin. Nuclear magnetic resonance spectroscopy (1H NMR, 2D ROESY, and DOSY) and mass spectrometry experiments were used for the study and characterization of the supramolecular complex revealing the effective inclusion of the PF11 in the γ-cyclodextrin cavity. The thermodynamic parameters and the geometry of the PF11/cyclodextrin inclusion complex were studied by molecular dynamics simulations and semi-empirical calculations. The results of this study might lead the way for new PF11/γ-cyclodextrin formulations with advanced bioavailability and targeting.
We also recommend Trading Suppliers and Manufacturers of F11 (cas 19340-14-8). Pls Click Website Link as below: cas 19340-14-8 suppliers
Prev:Biodegradation of Diclofenac by the bacterial strain Labrys portucalensis F11 (cas 19340-14-8)
Next:Pseudoginsenoside-F11 (cas 19340-14-8) Protects against Transient Cerebral Ischemia Injury in Rats Involving Repressing Calcium Overload) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Assessing the stoichiometric efficacy of mammalian expressed paraoxonase-1 variant I-F11 (cas 19340-14-8) to afford protection against G-type nerve agents08/10/2019
- Humanization of JAA-F11 (cas 19340-14-8), a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis08/09/2019
- Pseudoginsenoside-F11 (cas 19340-14-8) alleviates cognitive deficits and Alzheimer’s disease-type pathologies in SAMP8 mice08/08/2019
- Enantioselective degradation of ofloxacin and levofloxacin by the bacterial strains Labrys portucalensis F11 (cas 19340-14-8) and Rhodococcus sp. FP108/07/2019
- Preclinical Analysis of JAA-F11 (cas 19340-14-8), a Specific Anti–Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging08/06/2019
- Pseudoginsenoside-F11 (cas 19340-14-8) Protects against Transient Cerebral Ischemia Injury in Rats Involving Repressing Calcium Overload08/05/2019
- Biodegradation of Diclofenac by the bacterial strain Labrys portucalensis F11 (cas 19340-14-8)08/03/2019
- Carbamazepine is degraded by the bacterial strain Labrys portucalensis F11 (cas 19340-14-8)08/02/2019


